Summary of this blog
- A HealthTech growth consultant is hired at the plateau: the point where the first customers came from the founder’s network and the next ones have not come from anywhere. The job is to find out why, rebuild the engine around the buyer who is left, make the pipeline number repeatable and leave a team that can scale it.
- Plateaus are usually self-inflicted. Harvard Business Review’s study of growth stalls found 87% of root causes within management’s control, in four patterns: premium-position captivity, a breakdown in innovation management, premature abandonment of the core, and a talent bench shortfall. Each has a HealthTech version.
- The buyer has moved on without the company. 6sense’s 2025 report found buyers contact a vendor 61% of the way through the journey and that the first vendor contacted wins eight deals in ten. Gartner reports 75% of B2B buyers prefer a rep-free experience. A founder’s phone cannot reach a buyer who researches in silence.
- The four jobs run in order: diagnosis in the first month, the engine in the second and third, a repeatable number by the second quarter. Then a handover that leaves the marketing lead, the agency or the hire able to run the machine.
- Judge the engagement by qualified pipeline from sources other than the founder, cost per opportunity that holds across two quarters, and a team that can explain the engine without the consultant in the room.
A HealthTech growth consultant is hired at a specific moment: the plateau. The first ten or twenty customers came from the founder’s network, a conference, a clinical champion or a well-timed pilot. Then the network ran out, the pilot did not turn into a rollout, and the pipeline chart went flat. The consultant’s job is to find out why and rebuild the engine so that customers arrive from somewhere other than the founder’s phone. Then to make the number repeatable and leave a team that can scale it.
The plateau is rarely bad luck. Harvard Business Review’s study of growth stalls across Fortune 100 and Global 100 companies found 87% of the root causes within management’s control and only 13% external. The causes fell into four patterns: premium-position captivity, a breakdown in innovation management, premature abandonment of the core, and a talent bench shortfall. Every one of them has a version in a Series A health company, and the diagnosis is the first thing a HealthTech growth consultant is paid for.
This guide to hiring a HealthTech growth consultant is for the founder or CEO of a digital health, MedTech or health SaaS company whose early traction has flattened. The stage is Series A to Series B, in the US, the UK or Europe. Our companion piece on why HealthTech startups stall after early traction describes the problem; this one describes the work. Our pillar on the HealthTech marketing agency model covers the alternative of buying the engine and the hands together.
Early traction is the founder’s network converting. The plateau is the day the network runs out and the company finds out whether it has a marketing engine or a founder with a phone. A HealthTech growth consultant is hired on that day.
Why the buyer has moved on without you
6sense’s 2025 Buyer Experience Report, drawn from nearly 4,000 B2B buyers, found that buyers first contact a seller 61% of the way through their journey and that the vendor contacted first wins eight deals in ten. Gartner reports 75% of B2B buyers prefer a rep-free experience. The founder’s network worked because the founder was in the room. Now the next hundred hospital buyers are researching in a room the founder cannot enter, and the engine has to be there instead.
1. Diagnose why the traction stopped
The first job is a diagnosis the founder recognises as true. A HealthTech growth consultant spends the first three to four weeks on the data and the conversations. That means the CRM, the analytics, the lost-deal notes and the pilots that did not convert. Then six to ten conversations with customers, lapsed prospects and the sales team. The output is a short document naming the two or three causes that explain most of the plateau. A consultant who arrives with the answer has not diagnosed anything.
The four stall patterns a HealthTech growth consultant looks for
HBR’s four patterns map cleanly. Premium-position captivity is the MedTech company that keeps selling to academic centres while community hospitals buy a cheaper rival. A breakdown in innovation management is the health SaaS product that has not shipped a feature the buyer asked for in a year. Premature abandonment of the core is the digital health company that chased employers before it had finished winning payers. A talent bench shortfall is the marketing team of one generalist reporting to a founder who used to do the selling. A HealthTech growth consultant names which one applies, and usually two apply at once.
What the diagnosis looks like when it is done
One page. First, the buyer who bought, described by role and moment, and the buyer the company has been pursuing since, described the same way, with the gap between them named. Then the three sources of the last twenty opportunities, the point in the funnel where the pipeline leaks, with the number, and the claims on the website read against the product’s regulatory status. At Healthora, we have seen that founders who read a diagnosis and say “yes, that is us” commit to the rebuild; founders handed a forty-page deck tend to commission another one.
The question a HealthTech growth consultant asks first
Where did the last twenty opportunities come from, by name? Founders usually answer with channels. A HealthTech growth consultant wants sources: which person, which event, which search, which referral. When the list is read out, most companies at the plateau find that fifteen of the twenty came from the founder or one salesperson. The marketing programme produced two. That sentence is the diagnosis, and everything after it is the rebuild.
2. Rebuild the engine around the buyer who is left
The second job is the engine: the buyer, the position, the channels and the pages, rebuilt around the buyer who is still available to the company. Sometimes that is the buyer who bought at the start, reached in a repeatable way. Sometimes the diagnosis shows that the early customers were unusual: a few innovators with budget and patience. The company now has to win the cautious majority on different evidence. A HealthTech growth consultant decides which, and the decision changes everything downstream.
The evidence the cautious buyer needs
TrustRadius’s 2024 B2B Buying Disconnect, from 2,164 technology buyers, found 66% prefer established products, 63% shortlist two or three vendors, and 78% already knew the products they bought before the purchase began. The early adopters bought on promise. Later buyers buy on proof: outcomes from a site like theirs, a clinical champion who will take a call, an integration that already works with their record system. So the engine has to put that proof where the buyer is looking before the shortlist forms. Our guide to HealthTech demand generation covers how that proof becomes a programme.
Channels a HealthTech growth consultant chooses from the buyer’s moment
McKinsey’s 2024 B2B Pulse, drawn from nearly 4,000 decision makers, found buyers use an average of ten channels and that companies offering a real hybrid of in-person, remote and self-serve grew faster than those that did not. A HealthTech growth consultant picks the three channels where the rebuilt buyer researches and runs those to depth. Usually that means search with an evidence page behind it, a referral programme through current customers and clinical champions, and email to a pipeline the company already owns. Our guide to the HealthTech growth strategy sets out the sequencing.
What the rebuilt engine looks like at week twelve
A homepage and two or three pages that speak to the rebuilt buyer, with claims the regulator allows. A written position the sales team uses on calls. An evidence page with outcomes and references. A referral ask in the customer success process. A search programme against the buyer’s own questions. And a brief for whoever executes, whether an agency or the team. A HealthTech growth consultant who leaves the engine as a plan rather than as live pages has done half the second job.
A specialist’s view on your plateau
Not sure why the traction stopped, or what to rebuild first?
Book a free consultation with Healthora. We’ll run the first diagnostic questions with you, tell you candidly what the data suggests, and share practical recommendations you can act on straight away, whether you decide to work with us or not.
Book a Free Consultation3. Make the number repeatable
The third job is the one that separates growth from a good quarter. A HealthTech growth consultant is not judged on the first month of new pipeline, which any competent campaign can produce. She is judged on whether the pipeline arrives again in the second quarter, from the same sources, at a cost per opportunity the board can plan around. Repeatable means the company knows, within a range, what next quarter’s pipeline will be and what it will cost, and can spend against that knowledge.
The number and its definitions
Qualified pipeline and cost per opportunity, with “qualified” defined as the sales team would define it: the right role at the right kind of organisation, a stated problem, a timeframe. The definitions are written before the first count, because the disputes about them consume more board time than the pipeline does. A HealthTech growth consultant reports the number on one page every month, with the sources listed. The founder’s own introductions get their own line, so everyone can see the engine’s share rising.
Why a HealthTech growth consultant needs two quarters in health
Hospital and health system buying cycles are long, procurement committees meet on their own schedule, and a pilot takes a quarter to run. A HealthTech growth consultant who promises a repeatable number in ninety days is promising the wrong thing. The first quarter proves that the engine produces opportunities; the second proves that it does so again, without the founder, at a stable cost. Rock Health recorded $6.4 billion of US digital health funding across 245 deals in the first half of 2025, and every one of those companies will be asked by its next investor for exactly this two-quarter proof.
The report a HealthTech growth consultant should produce
One page from the HealthTech growth consultant. Qualified opportunities this month, by source, with the founder’s introductions on their own line. Cost per opportunity, this month and the trailing quarter. Pipeline value by stage. Three things that changed and one decision the board needs to make. A report longer than a page is hiding something, usually the fact that the engine’s share is not rising. Our guide to the HealthTech marketing audit shows the same page from the reviewer’s side.
4. Leave the team able to scale it
The fourth job is the handover. A growth consultant who becomes the engine has recreated the problem she was hired to solve, with a different name on the bottleneck. By the end of the engagement, someone in the company owns the number, someone runs each channel, and the documents that describe the engine exist. A HealthTech growth consultant plans this from the first month. The shape of the team she leaves behind decides whether the second quarter’s number becomes the fourth quarter’s.
Who owns the engine afterwards
Three shapes work after a HealthTech growth consultant leaves. A marketing lead in the building, with an agency for the disciplines the company cannot yet employ. A fractional CMO on two days a week, directing an agency or a small team. Or a strong marketing manager running a documented programme with a quarterly strategy review from outside. The ANA’s in-house agency study found 82% of member companies now have some in-house capability and 92% of those still use external agencies, which is the hybrid most health companies end up running. Our guide to the fractional CMO for HealthTech covers the second shape in detail.
What a HealthTech growth consultant hands over
The diagnosis, so the company remembers why it changed course. Then the buyer definition and the position, a page each, and the channel plan for the next two quarters with owners and costs. After that the claims register, the one-page report and its definitions, and a hiring brief for the marketing lead, if that is the shape chosen, with the consultant on the interview panel. And a review date. Gartner’s 2025 CMO Spend Survey found 59% of CMOs saying their budget cannot deliver their strategy, which is the argument for a plan sized to the money before the consultant leaves.
The sign a HealthTech growth consultant’s handover worked
Ask the marketing lead, three months after the HealthTech growth consultant leaves, to explain the engine to a new board member without the consultant in the room. Buyer, position, channels, number, cost, what changes next quarter. A clear ten-minute answer means the company owns its growth. At Healthora, we have seen that companies which can give that answer keep the engine running through a leadership change. Companies that cannot tend to be back at the plateau within a year, with a new consultant.
A HealthTech growth consultant in practice: the first two quarters
A HealthTech growth consultant engagement that does the four jobs runs across two quarters. Month one is the diagnosis: the data, the twenty-opportunity list, the conversations, the one-page document the founder signs. Months two and three are the engine: the buyer settled, the position tested on calls, the pages rebuilt around claims the regulator allows. The three channels are chosen and briefed and the first report is produced. The second quarter runs the engine and measures it, month by month, with the founder’s own introductions shown separately so the engine’s share is visible.
Companies whose HealthTech growth consultant runs the two quarters this way usually notice the change first in the source column of the report. Opportunities begin to arrive from search, from referrals and from the pipeline the company already owned, and the founder’s line stops being the biggest. Then the second quarter’s cost per opportunity holds close to the first’s. That is the moment the board starts to treat marketing spend as an investment with a return rather than a cost with a hope.
The recap below lists the four jobs a HealthTech growth consultant does, in the order they run.
- Diagnose why the traction stopped. Three to four weeks of the HealthTech growth consultant’s time, a one-page document the founder recognises as true, built on the last twenty opportunities by name and HBR’s four stall patterns.
- Rebuild the engine around the buyer who is left. Buyer, position, channels and pages, rebuilt for the cautious majority on proof rather than promise, live by week twelve.
- Make the number repeatable. Qualified pipeline and cost per opportunity, defined by the HealthTech growth consultant before counting, reported on one page a month, proved across two quarters.
- Leave the team able to scale it. A marketing lead, a fractional CMO or a manager with an agency, holding the documents, the report and the review date, able to explain the engine without the HealthTech growth consultant in the room.
Hiring a HealthTech growth consultant is one way to get past the plateau. The others are an agency with a strategy layer that diagnoses and then builds the engine, or a fractional leader who owns the number for a year. A full-time head of marketing hired early enough can also do the diagnosis herself. Our guide to the HealthTech marketing consultant covers the project-based version, and our services and case studies show what the agency route looks like in practice.
A specialist in health understands that the cautious buyer researches in silence, that every claim answers to a regulator, and that a health buying cycle takes two quarters to prove anything. Whichever route you choose, ask for the four jobs by name and for the one-page report by month four. A HealthTech growth consultant who cannot describe both is offering a good quarter, and you have already had one of those.
Ready to find out what stopped the traction?
HEALTHORA SPECIALISES IN HEALTH
Book a free consultation with Healthora. We’ll look at your last twenty opportunities with you, identify the growth opportunities the data points to, and share practical recommendations you can apply immediately, whether you decide to work with us or not.
Book a Free ConsultationFrequently asked questions
What does a HealthTech growth consultant do?
A HealthTech growth consultant is hired when a health technology company’s early traction has flattened. She diagnoses why the growth stopped and rebuilds the marketing engine around the buyer the company can still win. Then she makes qualified pipeline repeatable at a known cost per opportunity and hands the engine to a team that can scale it. The engagement usually runs two quarters, because a health buying cycle takes that long to prove anything.
When should a HealthTech company hire a growth consultant?
Hire a HealthTech growth consultant at the plateau: when the first ten to twenty customers came from the founder’s network, a pilot or a clinical champion, and the next ones have not come from anywhere for two or more quarters. Before that point, the company is still finding its buyer and a strategy consultant or a founder-led diagnosis is the better spend. After a rebuilt engine exists, the need is execution, which is an agency or a hire.
What is the difference between a growth consultant and a marketing consultant?
A marketing consultant answers a defined question, such as positioning, a channel plan or a website, and hands over a recommendation. A HealthTech growth consultant owns the whole plateau problem across two quarters: the diagnosis, the rebuilt engine, a repeatable pipeline number and the handover. The growth engagement is longer, is judged on a number rather than a deliverable, and usually ends with a hire or an agency in place.
How long does it take to see results?
New opportunities usually appear in the second or third month, once the rebuilt pages and the first channels are live. A repeatable number takes two quarters, because hospital and health system buyers move on their own schedule and a pilot takes a quarter to run. A HealthTech growth consultant who promises repeatable pipeline in ninety days is promising a good month.
How much does a HealthTech growth consultant cost?
Fees for a HealthTech growth consultant depend on the scope, the seniority and whether the engagement includes execution or only the diagnosis, the engine and the reporting. Most are structured as a monthly fee across two quarters. The more useful comparison is with two more quarters at the plateau, and with what the next investor will ask to see. Book a consultation for a view on the right structure for your stage.
Does a growth consultant need health experience?
Yes. The diagnosis depends on knowing how a hospital committee, a payer or a clinician buys, and on reading the company’s claims against its regulatory status. The engine depends on knowing which evidence the cautious health buyer needs before the shortlist forms. A generalist HealthTech growth consultant spends the first two months learning both, and the company has usually run out of those months.
How do I judge a growth consultant’s work?
By month four, a one-page report from the HealthTech growth consultant with qualified opportunities by source, the founder’s introductions on their own line, and cost per opportunity for the trailing quarter. At month six, the same report showing the engine’s share rising and the cost holding. When the engagement ends, a named owner for the number and a team that can explain the engine to a new board member without the consultant in the room.
Keep reading
More on growth, strategy and who delivers it in health: